NASDAQ
EUDA
Last Price
US $11.18
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
EUDA Health Holdings Limited cash flow to debt ratio of -101.05% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
EUDA Health Holdings Limited's free cash flow has decreased 17.68% from $-2.15M last year to $-2.53M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
EUDA Health Holdings Limited's debt to equity ratio is -0.56, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
EUDA Health Holdings Limited's debt to equity ratio is -0.56, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Net debt/EBITDA.
EUDA Health Holdings Limited has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
EUDA Health Holdings Limited's interest coverage ratio is -56.76, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
EUDA Health Holdings Limited's profit margin has increased (-89.38%) in the last year from -382.87% to -40.65%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
EUDA Health Holdings Limited's short-term liabilities of $5.84M exceed its short-term assets of $1.04M, signaling financial risk
Decreasing performance - ROA.
EUDA Health Holdings Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
EUDA Health Holdings Limited's return on equity of 69.63%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
EUDA Health Holdings Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
EUDA Health Holdings Limited had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
EUDA Health Holdings Limited has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
EUDA Health Holdings Limited has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
EUDA Health Holdings Limited's yearly earnings has increased -81.94% since last year from $-15.36M to $-2.77M, signaling increasing performance
Increasing performance - Healthy revenue growth.
EUDA Health Holdings Limited's yearly revenue has increased 70.04% since last year from $4.01M to $6.82M, signaling increasing performance
Increasing performance - ROIC.
ROIC 138.82% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
EUDA Health Holdings Limited's 3-year revenue CAGR of 21.91% is positive, indicating growing revenue over the past 3 years
Decreasing performance - Revenue consistency.
EUDA Health Holdings Limited had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Decreasing performance - ROE consistency.
EUDA Health Holdings Limited had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
EUDA Health Holdings Limited has insufficient data to evaluate this check.
Overvalued - Earnings yield.
EUDA Health Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
EUDA Health Holdings Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
EUDA Health Holdings Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
EUDA Health Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
EUDA Health Holdings Limited has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
EUDA Health Holdings Limited has a price-to-sales ratio of 3.08x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
69.63%
Return on equity
ROIC: 138.82%
Valuation History
-7.6X
Price to Earnings
EV/EBITDA: -10.3X
Cash flow
Profit margin
-20.37%
(FY vs FY)
Cash flow Y/Y
-28.05%
(FY vs FY)
Fair Value
Market $11.18
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.